Carnitine / radang

Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel disease

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to a new therapeutic use of the lower alkanoyl L-carnitines and their pharmacologically acceptable salts to produce pharmaceutical compositions for the treatment of chronic inflammatory bowel diseases, and, in particular, ulcerative colitis. The present invention also

Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to a new therapeutic use of the lower alkanoyl L-carnitines and their pharmacologically acceptable salts to produce pharmaceutical compositions for the treatment of chronic inflammatory bowel diseases, and, in particular, ulcerative colitis. The present invention also

Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

This application is a 371 of PCT/IT00/00158 filed Apr. 19, 2000. The present invention relates to a composition for the prevention and/or treatment of cardiovascular and neurocerebral disorders, various tissue anoxic forms, energetic muscular deficits, inflammatory type-abnormalities, blood

Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION The invention relates to methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions, particularly arthritis and joint pain, in canines, comprising measuring inflammatory biomarkers wherein elevated levels of the biomarkers in blood

Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

This application is a 371 of PCT/IT99/00364 filed Nov. 11, 1999. The present invention relates to complexes of hyaluronic acid and "carnitines", the latter herein meaning both carnitine as it is and, more specifically, its acyl derivatives with straight or branched chain aliphatic carboxylic acids,

Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION Amantadine (1-aminoadamantane) is an antiviral agent in clinical use. [See for example, Aldrich, P. E. et al., J. Med. Chem. 14, 535-543 (1972).] Memantine (3,5-dimethyl-1-adamantanamine) and its pharmaceutically acceptable salts are approved for the treatment of moderate to

Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION Amantadine (1-aminoadamantane) is an antiviral agent in clinical use. [See for example, Aldrich, P. E. et al., J. Med. Chem. 14, 535-543 (1972).] Memantine (3,5-dimethyl-1-adamantanamine) and its pharmaceutically acceptable salts are approved for the treatment of moderate to

Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to a composition suitable both for the prevention of articular disorders and for the therapeutic treatment of articular diseases. Accordingly, the composition may take the form and exert the activity of a food or dietary supplement or of an actual medicament in the

Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

HMB uses thereof

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

Acetylsalicylic acid salts

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF INVENTION The present invention relates in general to acetylsalicylic acid salts, and in particular to a new and useful water soluble acetylsalicylic acid salts and the method of making the same. Acetylsalicylic acid is a most widely used drug, known chiefly for its analgesic properties.

Equine nutritional supplement

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to nutritional supplements for humans, animals, and, more particularly, to nutritional supplements for equines, and even more particularly for racehorses. 2. Description of the Prior Art The training of

carnitine/radang

Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel disease

Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases

Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines

Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions

Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses

Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses

Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders

Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

HMB uses thereof

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

Acetylsalicylic acid salts

Equine nutritional supplement

Database tanaman obat terlengkap yang didukung oleh sains